Additionally, evidence has shown that inhibition of miR-103 can up-regulate NCX1 gene, thus reduce the volume of cerebral infarction after stroke, and improve the neurological deficit after stroke [20]. The gene discussed is SLC8A1; the disease is stroke disorder.